Fortune· 181d ago· 1 min read
After leading Pfizer through the frantic race to develop the first FDA-approved COVID-19 vaccine, CEO Albert Bourla has set his sights on a new, arguably more difficult moonshot. “We saved the world from Covid, now we'll save the world from cancer,” Bourla told Fortune Editor-in-Chief Alyson Shontell, outlining the company’s massive pivot toward oncology following the pandemic.
This ambition is backed by a historic reallocation of capital. Pfizer reinvested its pandemic-era windfalls into a $23 billion spending spree in 2023, targeting new business development opportunities to secure the company's future.
In an appearance on Fortune 's Titans and Disruptors of Industry video podcast, Bourla talked about the triumphs and challenges of navigating the pharmaceutical giant through the pandemic and what is shaping up afterward. Describing 2023 as a “very difficult period for me,” Bourla…
Continue reading at FortuneDiscussion
Be the first to comment.
Never miss a headline
Get breaking Nigerian and world news straight to your inbox.
Related Articles
Stocks making the biggest moves after hours: Apple, Amazon, Rivian, Reddit & more
5m ago
Read MoreCoinbase shares fall after crypto exchange posts disappointing second-quarter results
20m ago
Read More
Trump Passport Slated For Nationwide Release—What To Know About The ‘Patriot Passport’
59m ago
Read More
Trump Approval Rating Hits Record-Low In A Third Measurement This Week
1h ago
Read More
Trump’s Low Approval Rating Is Getting Even Worse: Here’s Why
1h ago
Read More
Burnham says he told Trump UK will be pragmatic about North Sea oil
5h ago
Read MoreLatest in Business
Alignment Healthcare LLC earnings beat by $0.04, revenue fell short of estimates
Investing.com · 15m ago
Can credit cards survive AI shopping? Why Mastercard’s CEO says they’ll ‘prevail’ in this new era.
MarketWatch · 15m ago
Penumbra Inc earnings missed by $0.28, revenue topped estimates
Investing.com · 15m ago
Why is Stryker stock tumbling today?
Investing.com · 16m ago
Eldorado Gold names Dan Myerson as board chair
Investing.com · 19m ago
Erie Indemnity earnings beat by $0.10, revenue was in line with estimates
Investing.com · 20m ago
CubeSmart beats EPS estimates, shares rise
Investing.com · 20m ago
First Solar beats Q2 earnings on higher margins
Investing.com · 21m ago
Most Read Today
Real Madrid close in on Yan Diomande as PSG withdraw from race
Yahoo Sports · 4d ago
LeBron James officially joins 76ers on two-year contract | Report
Yahoo Sports · 4d ago
FG predicts drop in cooking gas prices
Daily Trust · 2d ago
Insecurity: Group commends Tinubu’s approval of 12 new Nigerian Army Divisions
Nigerian Tribune · 2d ago
Six students sustain minor injuries as fire destroys Leklebi SHS House Master's apartment
3News · 5d ago
Innoviz Technologies stock tumbles 30% on share offering
Investing.com · 2d ago
West Ham United Are Keeping Tabs On Lazio Attacker: Does He Fit Into What The Hammers Want?
Yahoo Sports · 2d ago
Liverpool told to move for La Liga defender this summer
Yahoo Sports · 4d ago